No images? Click here Wednesday, 02 August 2023 NOTE TO MEDIA WHO EPI-WIN webinar Managing Dengue: a rapidly expanding epidemic 13:00–14:00 CEST, Wednesday 2 August 2023
Dengue (also known as bone-break fever) is a viral infection caused by the dengue virus (DENV), transmitted to humans through the bite of infected mosquitoes. The incidence of dengue has grown dramatically around the world in recent decades. Dengue is endemic in more than 100 countries in the WHO Regions of Africa, the Americas, the Eastern Mediterranean, South-East Asia and the Western Pacific. Dengue is spreading to new areas, including Europe, and explosive outbreaks are occurring. About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year. While many infections are asymptomatic or produce only mild illness, DENV can occasionally cause more severe cases and even death. Prevention and control of dengue depend on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue. This webinar will give an overview of the current situation across the world and the speakers will discuss the latest evidence on managing Dengue successfully. Interpretation for this webinar will be available in French, Spanish, and Portuguese. Speakers:
Q&A: Participants will be able to submit questions during the webinar by using Zoom's "Q&A" feature. Participants may also submit questions in advance by sending them to epi-win@who.int The webinar can also be viewed live and post-event on the EPI-WIN YouTube channel. Access EPI-WIN webinars page to learn about previous webinars. To receive EPI-WIN webinar invitations, please subscribe here Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list. |
Wednesday, August 2, 2023
WHO EPI-WIN webinar: Managing Dengue: a rapidly expanding epidemic, 13:00–14:00 CEST, Wednesday 2 August 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment